LIQUID 100
PRODUCT DESCRIPTION
Liquid biopsy NGS panel designed to target a comprehensive set of 100 over genes frequently found mutated in various cancers. This panel accurately identify genetic alterations and provide valuable insights into potential treatment options, prognostic indications, and implications for chemotherapy recommendations.
HIGHLIGHTED GENES
EGFR, ALK, ROS1, RET, BRAF, MET, ERBB2, BRCA1, BRCA2, NTRK1-3, DPYD, CYP2D6, UGT1A1, etc.
ALTERATIONS DETECTED
SNVs, InDels, Fusions/Rearrangements, CNVs, SNPs.